Product image of Xeomin (Clostridium Botulinum Neurotoxin Type A (150kd), Free Of Complexing Proteins) supplied by GNH India

Xeomin

Active Ingredient:
Clostridium Botulinum Neurotoxin Type A (150kd), Free Of Complexing Proteins
Origin:
EU

Xeomin (Clostridium Botulinum Neurotoxin Type A (150kd), Free Of Complexing Proteins)

Xeomin is a purified botulinum toxin type A used for temporary muscle relaxation and wrinkle reduction. It contains no complexing proteins and is administered via injection. Ideal for cosmetic and therapeutic applications. Suitable for those seeking non-surgical treatment options.

Manufacturer / TM Owner

Merz Pharmaceuticals Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xeomin is primarily used to temporarily relax facial muscles, reducing the appearance of wrinkles such as frown lines, crow’s feet, and forehead lines. It is also used therapeutically for conditions involving muscle overactivity, including cervical dystonia and blepharospasm. The treatment targets specific muscles to provide a smoother appearance. It is not a permanent solution but offers noticeable results.

Side Effects

  • After treatment, patients typically notice a gradual reduction in muscle activity within a few days, with full effects appearing in about two weeks. Results can last three to six months, depending on individual factors. Some may experience mild redness, swelling, or bruising at the injection site. These effects are usually temporary and resolve quickly.

Precautions & Warnings

  • Xeomin should only be administered by a qualified healthcare professional experienced in the use of botulinum toxin. Patients with neuromuscular disorders or infections at the injection site should avoid treatment. It is important to disclose all medical conditions and medications to the provider before treatment. Avoid rubbing or massaging the treated area post-injection to prevent spreading the toxin.

Avoid Interactions

  • Xeomin may interact with medications that affect neuromuscular transmission, such as muscle relaxants or certain antibiotics. Patients taking blood thinners or anti-inflammatory drugs should inform their provider, as these may increase the risk of bruising. Alcohol and large doses of vitamin E or omega-3 supplements should be avoided before and after treatment to minimize bleeding risks.

Frequently Asked Questions

Xeomin is used to temporarily reduce the appearance of facial wrinkles and treat muscle overactivity conditions like cervical dystonia.

Results typically last three to six months, though this varies by individual and treatment area.

Xeomin should be avoided by those with neuromuscular disorders or infections at the injection site. Consult a healthcare provider for suitability.

Common side effects include mild redness, swelling, or bruising at the injection site, which usually resolve quickly.

Xeomin is not typically used for migraines but may be prescribed off-label for certain conditions. Consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clostridium Botulinum Neurotoxin Type A (150kd), Free Of Complexing Proteins

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT